TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.220
-0.005 (-0.40%)
Mar 31, 2025, 10:51 AM EDT - Market open
TELA Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TELA Bio stock have an average target of 6.00, with a low estimate of 2.00 and a high estimate of 8.00. The average target predicts an increase of 391.80% from the current stock price of 1.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TELA Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +473.77% | Mar 21, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +473.77% | Mar 21, 2025 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $2 | Buy → Hold | Downgrades | $5 → $2 | +63.93% | Mar 21, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +309.84% | Nov 8, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +883.61% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
95.66M
from 69.30M
Increased by 38.03%
Revenue Next Year
118.98M
from 95.66M
Increased by 24.38%
EPS This Year
-0.66
from -1.33
EPS Next Year
-0.37
from -0.66
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 99.2M | 126.5M | 157.5M | |
Avg | 95.7M | 119.0M | 153.0M | |
Low | 90.9M | 110.5M | 147.0M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 43.2% | 32.2% | 32.4% | |
Avg | 38.0% | 24.4% | 28.6% | |
Low | 31.2% | 15.5% | 23.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.47 | -0.11 | 0.30 | |
Avg | -0.66 | -0.37 | 0.15 | |
Low | -0.84 | -0.64 | 0.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.